Bio-Path Holdings, Inc. (OTC:BPTH) People

Bio-Path Holdings, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mark P Colonnese
Other companies: Vaxart, Inc. (Chief Financial Officer · Nov 2, 2015 – Apr 3, 2017 · Past); Precipio, Inc. (Chief Financial Officer · Sep 12, 2012 – Feb 18, 2014 · Past); Atherogenics Inc (VP Commercial Operations & CFO · Feb 21, 2006 – Dec 31, 2008 · Past)
Director · Jul 13, 2017 – Mar 28, 2019 · Past
Gillian C Ivers-Read
Other companies: Clovis Oncology Inc (See Remarks · Nov 15, 2011 – Nov 1, 2022 · Past); Pharmion Corp (EVP, Development Operations · Dec 31, 2005 – Mar 7, 2008 · Past)
Director · Sep 10, 2008 – Apr 25, 2014 · Past
Aline SherwoodDirector · Mar 31, 2022 – Jul 30, 2024 · Past
Amy SingDirector · Nov 3, 2014 – Mar 23, 2017 · Past
Douglas P MorrisDirector · Sep 10, 2008 – Jul 30, 2024 · Past
Heath CleaverDirector · Feb 11, 2014 – Jul 30, 2024 · Past
Michael J GarrisonDirector · Oct 1, 2012 – Mar 23, 2017 · Past
Paul AubertDirector · Feb 1, 2018 – Jul 30, 2024 · Past
Peter Henry NielsenPresident, CEO & CFO, Director · Mar 28, 2019 – Jul 30, 2024 · Past
Tamaro Martina MolsbergenDirector · Oct 11, 2019 – Mar 31, 2021 · Past
Thomas E GarrisonDirector · Sep 10, 2008 – Dec 2, 2009 · Past
Ulrich W MuellerCOO & Secretary · Mar 26, 2014 – May 1, 2017 · Past
Vikram GroverCEO | Board Chairman · Since at least Nov 5, 2026
Wendy CharlesChief Scientific Officer and Chief Ethics & Compliance Officer · Since at least Nov 4, 2026